De Jaeghere EA, Hamerlinck H, Tuyaerts S, Lippens L, et al. Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial. Gynecol Oncol 2024;191:275-286.
PMID: 39515198